Study of the Prevalence of Pediatric Eating Disorders in Inherited Metabolic Diseases With Dietary Treatment

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-08-21

Study Completion Date

2026-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main objective of this study is to estimate the prevalence of Pediatric Eating Disorders (PED) in Inherited Metabolic Diseases (IMD) with dietary treatment between the age of 12 months and 6 years 11 months.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effects of Fecal Microbiota Transplantation

NCT07196189

Eating Disorders Symptoms

RECRUITING

Comparing the Effectiveness of Two Therapies to Treat Signs of Anorexia Nervosa in Adolescents

NCT00418977

Eating Disorders

COMPLETED NA

Development of Eating Disorders Symptoms Among Children

NCT02624713

Eating Disorders Symptoms

COMPLETED NA

Family-Based Treatment at Home in Adolescents With Eating Disorders and Co-occurring Mental Health Conditions

NCT06792227

Eating Disorders Anorexia Nervosa Eating Disorder Not Otherwise Specified

ENROLLING_BY_INVITATION NA

Pediatric Feeding Disorder Evolution in Amiens University Hospital

NCT06928714

Feeding Disorders Eating Behaviors Dysphagia +3 more

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Inherited Metabolic Diseases (IMDs) are rare conditions, which are the consequence of a genetic defect affecting an enzyme or a transporter involved in metabolism. This enzymatic defect leads to the accumulation of a potentially toxic compound located upstream of the deficiency and/or the absence of a compound located downstream of the defect. Treatment is possible and it consists of dietary and/or drug treatment.

Pediatric Eating Disorders (PED) cover "all the difficulties of oral feeding. These may be disorders due to absence of spontaneous feeding behavior, or refusal to eat, and disorders which affect the child's entire psychomotor, language and emotional development.

To date, the investigators note the absence of data on the prevalence of PED in IMDs and more generally on the quality of life and psychomotor development of these patients.

The causes and mechanisms of PED are numerous and heterogeneous. Their origins can be endogenous and/or exogenous.

Our main hypothesis is that the presence of PEDs varies depending on the different categories of IMDs with dietary treatment. Estimating their prevalence would enable awareness and early, better quality care.

This study aims to obtain clear and consistent results from a validated scale. It is a single-site study prospectively including patients from the Necker-Enfants Malades hospital reference center.

Parents will be informed of the study by an investigator (psychomotor therapist or dietician) during a phone call, by email or in hospital prior to the inclusion visit.

On the day of inclusion, the parent's and the child's (depending on their age) non-opposition will be collected before carrying out any procedure and recorded in the patient's medical file.

The MCH (Montreal children's hospital) scale and the parental questionnaire will be proposed by the study investigators at the same time, in a physical interview.

The collection of medical data in the patient's file and the rating of the MCH scale will be done in parallel by the study investigators.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Inherited Metabolism Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Children with Inherited Metabolism Disease (IMD) with dietary treatment

Children with Inherited Metabolism Disease (IMD) with dietary treatment planning to come for a hospital visit (in or out patient) as part of their standard care.

MCH (Montreal Children's Hospital) feeding scale questionnaire and parental questionnaire

Intervention Type OTHER

The patient's parents will answer the questionnaire and the investigator will complete the parental questionnaire while asking the questions.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MCH (Montreal Children's Hospital) feeding scale questionnaire and parental questionnaire

The patient's parents will answer the questionnaire and the investigator will complete the parental questionnaire while asking the questions.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient from 12 months to 6 years and 11 months old
* Patient with an Inherited Metabolic Diseases with dietary treatment
* Patient having experimented a dietary diversification at least 6 month prior
* Patient whose parents do not object to their participation in the study

Exclusion Criteria

* Patient with an associated chronic disease
* Patient with diagnosed Autistic Spectrum Disorder (ASD) or Pervasive Developmental Disorders (PDD)
* Patient born before 36 weeks of amenorrhea
* Patient with multiple disabilities
* Patient with dystonia
* Patient with absent or unstable head posture
* Patient whose parents do not fully understand or speak French

Minimum Eligible Age

12 Months

Maximum Eligible Age

6 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No